MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 1231929-97-7
Formula C27H32F2N8MW 506.6Research-use catalog entryCOA/SDS by request

Abemaciclib

CAS Number: 1231929-97-7

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
1 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: UZWDCWONPYILKI-UHFFFAOYSA-NC27H32F2N8 | MW 506.6

Chemical Absolute Identifiers

CAS Number

1231929-97-7

PubChem CID

46220502

Molecular Formula

C27H32F2N8

Molecular Weight

506.6 g/mol

Exact Mass

506.271799

InChIKey

UZWDCWONPYILKI-UHFFFAOYSA-N

IUPAC Name

N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine

SMILES String

CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Abemaciclib (CAS 1231929-97-7) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C27H32F2N8 and molecular weight 506. 60 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Cyclin-dependent kinase 4 (Homo sapiens) — 13 assays; CDK6/cyclin D1 (Homo sapiens) — 10 assays; Cyclin-dependent kinase 4/cyclin D1 (Homo sapiens) — 16 assays; Dual specificity protein kinase CLK1 (Homo sapiens) — 7 assays; CDK4/Cyclin D3 (Homo sapiens) — 9 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Cyclin-dependent kinase 4

Homo sapiens · SINGLE PROTEIN · 13 qualifying assays · 13 documents · best pChEMBL 9.59

Experimental evidence source: ChEMBL

CDK6/cyclin D1

Homo sapiens · PROTEIN COMPLEX · 10 qualifying assays · 7 documents · best pChEMBL 9.37

Experimental evidence source: ChEMBL

Cyclin-dependent kinase 4/cyclin D1

Homo sapiens · PROTEIN COMPLEX · 16 qualifying assays · 12 documents · best pChEMBL 9.34

Experimental evidence source: ChEMBL

Dual specificity protein kinase CLK1

Homo sapiens · SINGLE PROTEIN · 7 qualifying assays · 4 documents · best pChEMBL 9.07

Experimental evidence source: ChEMBL

CDK4/Cyclin D3

Homo sapiens · PROTEIN COMPLEX · 9 qualifying assays · 7 documents · best pChEMBL 8.82

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Abemaciclib

Names & Synonyms

VerzenioN-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amineVerzeniosN-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amineLY 2835219
Show all synonyms
2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amineN-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl]pyrimidin-2-amineabemaciclibumN-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo(d)imidazol-6-yl)pyrimidin-2-amineN-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl)pyrimidin-2-amineN-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amineLY2835219 free base2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-Abemaciclib (ly2835219)s5716N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamineN-{5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amineAbemaciclib [USAN:INN]
External Identifiers
EC NUMBER: 806-670-8DSSTOX SUBSTANCE ID: DTXSID20673119CHEMBL ID: CHEMBL3301610CHEBI ID: CHEBI:233362UNII: 60UAB198HKDRUGBANK ID: DB12001HMDB ID: HMDB0247749KEGG ID: D10688METABOLOMICS WORKBENCH ID: 153067NCI THESAURUS CODE: C97660PHARMGKB ID: PA166153471RXCUI: 1946825WIKIDATA ID: Q23901483
Literature & Patent References
DOI 10.1016/j.ejmech.2025.117465Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy.DOI 10.1021/acs.jmedchem.4c01686Elucidating Binding Selectivity in Cyclin-Dependent Kinases 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors.PMID 39754579Elucidating Binding Selectivity in Cyclin-Dependent Kinases 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors.PMID 40037064Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy.DOI 10.1016/j.bmc.2023.117561Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.DOI 10.1016/j.bmcl.2024.129769Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor.DOI 10.1039/d3md00524kNovel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: <i>in silico</i> studies, synthesis, and biological evaluation.PMID 38157838Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

6-(2-Chloro-5-fluoro-4-pyrimidinyl)-4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazoleCAS 1231930-42-9
6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo(d)imidazoleCAS 1231930-33-8
5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinamineCAS 1180132-17-5
1-[(6-Bromopyridin-3-yl)methyl]-4-ethylpiperazineCAS 1231930-25-8
4-Fluoro-2-methyl-1-(1-methylethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazoleCAS 1231930-37-2

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 571190-30-2PalbociclibCAS 62996-74-1StaurosporineCAS 120685-11-2MidostaurinCAS 1231930-42-96-(2-Chloro-5-fluoro-4-pyrimidinyl)-4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazoleCAS 5308-25-81-EthylpiperazineCAS 1180132-17-55-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinamineCAS 443913-73-3VandetanibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 1231929-97-7

What are the key identifiers for Abemaciclib (CAS 1231929-97-7)?

Abemaciclib is identified by CAS 1231929-97-7, with molecular formula C27H32F2N8, molecular weight 506.6, InChIKey UZWDCWONPYILKI-UHFFFAOYSA-N.

Does CAS 1231929-97-7 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Cyclin-dependent kinase 4, CDK6/cyclin D1, Cyclin-dependent kinase 4/cyclin D1, Dual specificity protein kinase CLK1, CDK4/Cyclin D3. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 1231929-97-7?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Abemaciclib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 1231929-97-7 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.